Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Genmark Diagnostics (GNMK)

Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,756,987
  • Shares Outstanding, K 73,086
  • Annual Sales, $ 171,550 K
  • Annual Income, $ -18,640 K
  • 60-Month Beta 3.05
  • Price/Sales 10.24
  • Price/Cash Flow N/A
  • Price/Book 18.30
Trade GNMK with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.21
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 05/03/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility N/A
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.05
  • Number of Estimates 2
  • High Estimate -0.04
  • Low Estimate -0.06
  • Prior Year -0.04
  • Growth Rate Est. (year over year) -25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.84 +0.82%
on 04/12/21
24.25 -0.87%
on 03/26/21
unch (unch)
since 03/19/21
3-Month
12.76 +88.40%
on 01/29/21
24.25 -0.87%
on 03/26/21
+9.40 (+64.21%)
since 01/21/21
52-Week
8.42 +185.51%
on 04/22/20
24.25 -0.87%
on 03/26/21
+15.65 (+186.53%)
since 04/21/20

Most Recent Stories

More News
INVESTIGATION ALERT: Halper Sadeh LLP Investigates CLGX, KSHB, AEGN, GNMK; Shareholders Are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / April 12, 2021 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: CoreLogic, Inc. (NYSE: CLGX) concerning potential violations...

CLGX : 80.00 (+0.59%)
KSHB : 0.6950 (+0.14%)
AEGN : 29.99 (-0.03%)
GNMK : 24.04 (unch)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates MLND, KSHB, GNMK, ALXN; Shareholders are Encouraged to Contact the Firm

NEW YORK, April 06, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

MLND : 15.9000 (-5.36%)
KSHB : 0.6950 (+0.14%)
GNMK : 24.04 (unch)
ALXN : 182.50 (+1.70%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates TPCO, GNMK, FI, INSW; Shareholders Are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / April 5, 2021 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Tribune Publishing Company (NASDAQ:TPCO) concerning potential...

TPCO : 17.26 (+0.41%)
GNMK : 24.04 (unch)
FI : 152.15 (+1.68%)
INSW : 52.31 (+0.40%)
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates TPCO, DSSI, GNMK, BMTC; Shareholders are Encouraged to Contact the Firm

NEW YORK, April 01, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

TPCO : 17.26 (+0.41%)
DSSI : 9.69 (+2.00%)
GNMK : 24.04 (unch)
BMTC : 45.01 (-1.57%)
GENMARK ALERT: Bragar Eagel & Squire, P.C. Investigates Recently Announced Tender Offer for GNMK and Encourages Investors to Contact the Firm

NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, advises that a tender offer to acquire GenMark Diagnostics, Inc. (NASDAQ:...

GNMK : 24.04 (unch)
RHHBY : 32.1800 (-1.41%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates TPCO, STAY, GNMK, WIFI; Shareholders Are Encouraged to Contact the Firm

NEW YORK, March 25, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

TPCO : 17.26 (+0.41%)
STAY : 20.46 (unch)
GNMK : 24.04 (unch)
WIFI : 13.99 (+0.07%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of TPCO, FRTA, GNMK, and BMTC Buyouts

WILMINGTON, Del., March 24, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating:

TPCO : 17.26 (+0.41%)
FRTA : 24.00 (+4.03%)
GNMK : 24.04 (unch)
BMTC : 45.01 (-1.57%)
STOCK ALERT: Halper Sadeh LLP Investigates RMBL, STAY, GNMK, TPCO; Shareholders Are Encouraged to Contact the Firm

NEW YORK, March 18, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

RMBL : 5.71 (+8.14%)
STAY : 20.46 (unch)
GNMK : 24.04 (unch)
TPCO : 17.26 (+0.41%)
GENMARK INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of GenMark Diagnostics - GNMK

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of GenMark Diagnostics (NasdaqGM: GNMK) to F....

GNMK : 24.04 (unch)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of GenMark Diagnostics, Inc. Buyout

WILMINGTON, Del., March 15, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating GenMark Diagnostics, Inc. (“GenMark”) (NASDAQ GM: GNMK ) regarding possible breaches...

GNMK : 24.04 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor' XT-8 system is the second generation in GenMark Dx's eSensor' platform, utilizing electrochemical detection technology to detect nucleic...

See More

Key Turning Points

3rd Resistance Point 24.09
2nd Resistance Point 24.07
1st Resistance Point 24.06
Last Price 24.04
1st Support Level 24.03
2nd Support Level 24.01
3rd Support Level 24.00

See More

52-Week High 24.25
Last Price 24.04
Fibonacci 61.8% 18.20
Fibonacci 50% 16.33
Fibonacci 38.2% 14.47
52-Week Low 8.42

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar